• 1. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 2. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. An amphipathic trans-acting phosphorothioate RNA element delivers an uncharged phosphorodiamidate morpholino sequence in mdx mouse myotubes?
  H. V. Jain,D. Verthelyi,S. L. Beaucage RSC Adv., 2017,7, 42519-42528
• 5. An Aptamer Bio-barCode (ABC) assay using SPR, RNase H, and probes with RNA and gold-nanorods for anti-cancer drug screening
  Chengbin Yang,Hing Lun Tsang,Pui Man Lau,Ken-Tye Yong,Ho Pui Ho,Siu Kai Kong Analyst, 2017,142, 3579-3587

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of 2-Nitropyridine-3-carboxylic Acid (CAS: 33225-72-8)

2-Nitropyridine-3-carboxylic acid (CAS: 33225-72-8) is a key intermediate in the synthesis of various pharmaceutical compounds and agrochemicals. Recent studies have highlighted its potential as a building block for novel drug candidates, particularly in the development of anti-inflammatory and antimicrobial agents. This research brief aims to summarize the latest findings related to this compound, focusing on its chemical properties, synthetic applications, and biological activities.

A study published in the Journal of Medicinal Chemistry (2023) explored the use of 2-nitropyridine-3-carboxylic acid as a precursor for the synthesis of pyridine-based inhibitors targeting bacterial enzymes. The researchers demonstrated that derivatives of this compound exhibited significant inhibitory activity against Escherichia coli and Staphylococcus aureus, with minimal cytotoxicity to human cells. These findings suggest its potential as a lead compound for developing new antibiotics.

In another study (Bioorganic & Medicinal Chemistry Letters, 2024), 2-nitropyridine-3-carboxylic acid was utilized to synthesize novel nonsteroidal anti-inflammatory drugs (NSAIDs). The derivatives showed enhanced selectivity for cyclooxygenase-2 (COX-2) over COX-1, reducing the risk of gastrointestinal side effects commonly associated with traditional NSAIDs. This research opens new avenues for designing safer anti-inflammatory medications.

Recent advancements in synthetic methodologies have also improved the efficiency of producing 2-nitropyridine-3-carboxylic acid. A green chemistry approach reported in Organic Process Research & Development (2023) described a solvent-free, catalytic nitration process that increased yield by 15% while reducing environmental impact. This innovation is particularly relevant for industrial-scale production.

Ongoing research is investigating the compound's potential in cancer therapy. Preliminary results from in vitro studies indicate that certain metal complexes of 2-nitropyridine-3-carboxylic acid exhibit promising antiproliferative effects against various cancer cell lines, with mechanisms involving DNA intercalation and reactive oxygen species generation.

In conclusion, 2-nitropyridine-3-carboxylic acid (CAS: 33225-72-8) continues to be a versatile and valuable compound in pharmaceutical research. Its applications span from antimicrobial and anti-inflammatory agents to potential anticancer therapeutics. The recent developments in its synthesis and biological evaluation underscore its importance in drug discovery and warrant further investigation into its therapeutic potential.

• 33225-73-9(2-Nitropyridine-5-carboxylic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)